CapMan has expanded its life science team into Denmark with the appointment of Morten Bro Nielsen as investment director in the life science business unit. He will be responsible for the team’s investments in the Danish medical technology sector.
He joins CapMan from the diagnostics company Radiometer where for the last two years he was responsible for establishing and running the Radiometer Venture Fund, the corporate venture capital arm of Radiometer.
He has eight years experience of life science related companies and a broad international background having worked in Japan, France, the US, Sweden and Denmark. He has a PhD from the Technical University of Denmark and an MBA from INSEAD.
Jan Lundahl, head of CapMan’s life science business unit, said: “We now have a truly Nordic life science team with team members in Sweden, Finland and Denmark. With the addition of Morten to our team we have completed our transition from a national investor to a cross border life science investor.”